视神经脊髓炎谱系障碍-话题@MedSci - 梅斯（MedSci）

#视神经脊髓炎谱系障碍#

10篇内容 | 1571人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2220078, encodeId=133222200e8e2, content=<a href='/topic/show?id=51b92e03ab' target=_blank style='color:#2F92EE;'>#AQP4-IgG#</a> <a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=视神经脊髓炎谱系疾病(NMOSD), objectType=article, longId=838481, objectId=0a6783848175, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240622/1719045450188_5579292.png, objectUrl=/article/show_article.do?id=0a6783848175, replyNumber=0, likeNumber=47, createdTime=2024-08-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0a6783848175, moduleTitle=视神经脊髓炎谱系疾病(NMOSD), moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0a6783848175)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198002, encodeId=e07d2198002ad, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=JNNP：视神经脊髓炎谱系疾病：与妊娠有关的发作和预测危险因素, objectType=article, longId=203865, objectId=e7a2203865f8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201129/1606614530712_2026338.gif, objectUrl=/article/show_article.do?id=e7a2203865f8, replyNumber=0, likeNumber=54, createdTime=2024-04-11, rootId=0, userName=ms3000000180832363, userId=9f568413042, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=河北省, moduleDTOList=[ModuleDTO(moduleId=e7a2203865f8, moduleTitle=JNNP：视神经脊髓炎谱系疾病：与妊娠有关的发作和预测危险因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e7a2203865f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2177721, encodeId=494c21e772153, content=<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a> <a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a> <a href='/topic/show?id=971388025d1' target=_blank style='color:#2F92EE;'>#获得性血友病A#</a>, objectTitle=2023年度巨献：中国罕见病领域十大医学研究出炉, objectType=article, longId=807173, objectId=2efc80e17361, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231228/1703729896491_92910.png, objectUrl=/article/show_article.do?id=2efc80e17361, replyNumber=0, likeNumber=86, createdTime=2023-12-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2efc80e17361, moduleTitle=2023年度巨献：中国罕见病领域十大医学研究出炉, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2efc80e17361)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2124108, encodeId=b134212410826, content=<a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>能够安全有效治疗复发或难治性<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a><a href='/topic/show?id=fba610582034' target=_blank style='color:#2F92EE;'>#抗水通道蛋白4#</a>(aquaporin 4, AQP4)自身抗体的发现，使人们了解其病理生理和精确的靶向治疗浆细胞产生的多克隆免疫球蛋白G (immunoglobulin G，IgG)与视神经和脊髓上的<a href='/topic/show?id=ea7810582164' target=_blank style='color:#2F92EE;'>#AQP4#</a>结合，导致多种病理结果。, objectTitle=STTT：华中科技大学王伟团队证明CAR-T细胞疗法能够安全有效治疗复发或难治性视神经脊髓炎谱系障碍, objectType=article, longId=754853, objectId=48fbe548534c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=48fbe548534c, replyNumber=0, likeNumber=104, createdTime=2023-04-06, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=48fbe548534c, moduleTitle=STTT：华中科技大学王伟团队证明CAR-T细胞疗法能够安全有效治疗复发或难治性视神经脊髓炎谱系障碍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=48fbe548534c)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1555642, encodeId=a14a15556420c, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=JNNP:MRI的T2弛豫时间可作为视神经脊髓炎谱系障碍诊断的标志物, objectType=article, longId=728601, objectId=f983e2860101, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f983e2860101, replyNumber=0, likeNumber=95, createdTime=2022-06-05, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f983e2860101, moduleTitle=JNNP:MRI的T2弛豫时间可作为视神经脊髓炎谱系障碍诊断的标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f983e2860101)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555641, encodeId=7564155564170, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=JNNP:视网膜星形胶质细胞外层变薄不是AQP4 IgG血清阳性视神经脊髓炎谱系障碍的特征, objectType=article, longId=219589, objectId=017b219589de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=017b219589de, replyNumber=0, likeNumber=0, createdTime=2021-11-02, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=017b219589de, moduleTitle=JNNP:视网膜星形胶质细胞外层变薄不是AQP4 IgG血清阳性视神经脊髓炎谱系障碍的特征, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=017b219589de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555640, encodeId=6be51555640bf, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=JNNP:水通道蛋白-4抗体阳性视神经脊髓炎谱系障碍患者脑萎缩的无症状进展, objectType=article, longId=215755, objectId=cafd215e550d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cafd215e550d, replyNumber=0, likeNumber=84, createdTime=2021-08-16, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cafd215e550d, moduleTitle=JNNP:水通道蛋白-4抗体阳性视神经脊髓炎谱系障碍患者脑萎缩的无症状进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cafd215e550d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555639, encodeId=c2b61555639f6, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=JNNP：髓鞘少突胶质细胞糖蛋白抗体相关疾病，视神经脊髓炎谱系障碍中脑干和小脑受累对比, objectType=article, longId=205686, objectId=6ef4205686e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ef4205686e8, replyNumber=0, likeNumber=78, createdTime=2021-01-14, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ef4205686e8, moduleTitle=JNNP：髓鞘少突胶质细胞糖蛋白抗体相关疾病，视神经脊髓炎谱系障碍中脑干和小脑受累对比, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6ef4205686e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555638, encodeId=707f15556383f, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=Lancet Neurology：Satralizumab单药治疗视神经脊髓炎谱系障碍的安全性和有效性：一项随机、双盲、多中心、安慰剂对照的3期试验, objectType=article, longId=204612, objectId=b76e204612db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b76e204612db, replyNumber=0, likeNumber=65, createdTime=2020-12-18, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b76e204612db, moduleTitle=Lancet Neurology：Satralizumab单药治疗视神经脊髓炎谱系障碍的安全性和有效性：一项随机、双盲、多中心、安慰剂对照的3期试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b76e204612db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555637, encodeId=4647155563e7e, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=Lancet Neurology：Satralizumab治疗视神经脊髓炎谱系障碍（NMOSD），安全有效, objectType=article, longId=193031, objectId=f1fd19303162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1fd19303162, replyNumber=0, likeNumber=67, createdTime=2020-04-28, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1fd19303162, moduleTitle=Lancet Neurology：Satralizumab治疗视神经脊髓炎谱系障碍（NMOSD），安全有效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f1fd19303162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555636, encodeId=495e1555636f7, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=罗氏的白细胞介素6受体单抗Satralizumab治疗视神经脊髓炎谱系障碍的临床试验成功, objectType=article, longId=184086, objectId=1b3518408695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b3518408695, replyNumber=0, likeNumber=60, createdTime=2019-12-05, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b3518408695, moduleTitle=罗氏的白细胞介素6受体单抗Satralizumab治疗视神经脊髓炎谱系障碍的临床试验成功, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1b3518408695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1555635, encodeId=d11c15556353a, content=<a href='/topic/show?id=959290e2483' target=_blank style='color:#2F92EE;'>#视神经脊髓炎谱系障碍#</a>, objectTitle=NEJM：Eculizumab治疗AQP4-IgG阳性视神经脊髓炎谱系障碍, objectType=article, longId=165480, objectId=243816548025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=243816548025, replyNumber=0, likeNumber=70, createdTime=2019-05-08, rootId=0, userName=yuandd, userId=a90d14641218, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=243816548025, moduleTitle=NEJM：Eculizumab治疗AQP4-IgG阳性视神经脊髓炎谱系障碍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=243816548025)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

视神经脊髓炎谱系障碍

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#AQP4-IgG# #视神经脊髓炎谱系障碍#

视神经脊髓炎谱系疾病(NMOSD)

2024-08-14发表于上海

ms3000000180832363 (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

JNNP：视神经脊髓炎谱系疾病：与妊娠有关的发作和预测危险因素

2024-04-11发表于河北省

梅斯管理员 (审核中...)

前往app查看评论内容

#罕见病# #Car-T细胞疗法# #视神经脊髓炎谱系障碍# #获得性血友病A#

2023年度巨献：中国罕见病领域十大医学研究出炉

2023-12-28发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

全文收起 #CAR-T细胞治疗#能够安全有效治疗复发或难治性#视神经脊髓炎谱系障碍##抗水通道蛋白4#(aquaporin 4, AQP4)自身抗体的发现，使人们了解其病理生理和精确的靶向治疗浆细胞产生的多克隆免疫球蛋白G (immunoglobulin G，IgG)与视神经和脊髓上的#AQP4#结合，导致多种病理结果。

STTT：华中科技大学王伟团队证明CAR-T细胞疗法能够安全有效治疗复发或难治性视神经脊髓炎谱系障碍

2023-04-06发表于上海

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

JNNP:MRI的T2弛豫时间可作为视神经脊髓炎谱系障碍诊断的标志物

2022-06-05

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

JNNP:视网膜星形胶质细胞外层变薄不是AQP4 IgG血清阳性视神经脊髓炎谱系障碍的特征

2021-11-02

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

JNNP:水通道蛋白-4抗体阳性视神经脊髓炎谱系障碍患者脑萎缩的无症状进展

2021-08-16

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

JNNP：髓鞘少突胶质细胞糖蛋白抗体相关疾病，视神经脊髓炎谱系障碍中脑干和小脑受累对比

2021-01-14

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

Lancet Neurology：Satralizumab单药治疗视神经脊髓炎谱系障碍的安全性和有效性：一项随机、双盲、多中心、安慰剂对照的3期试验

2020-12-18

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

Lancet Neurology：Satralizumab治疗视神经脊髓炎谱系障碍（NMOSD），安全有效

2020-04-28

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

罗氏的白细胞介素6受体单抗Satralizumab治疗视神经脊髓炎谱系障碍的临床试验成功

2019-12-05

yuandd (审核中...)

前往app查看评论内容

#视神经脊髓炎谱系障碍#

NEJM：Eculizumab治疗AQP4-IgG阳性视神经脊髓炎谱系障碍

2019-05-08

科室
- - 订阅+
  - 更多科室
工具
服务